CLDI
Calidi Biotherapeutics, Inc.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors 3× in & out | Q3 2025 | Q4 2025 | — | +0% |
| Millennium Management | Q1 2025 | Q2 2025 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Calidi Biotherapeutics, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Dec 16, 2025 — the most recent Form 4 on file — not from today.
- Form 40001493152-25-028030Dec 16, 2025
- Form 40001641172-25-026782Sep 5, 2025
- Form 40001641172-25-026780Sep 5, 2025
- Form 40001641172-25-026781Sep 5, 2025
- Form 40001641172-25-025448Aug 25, 2025
- Form 40001641172-25-025447Aug 25, 2025
- Form 40001641172-25-025446Aug 25, 2025
- Form 40001641172-25-025445Aug 25, 2025
- Form 40001641172-25-019802Jul 15, 2025
- Form 40001641172-25-019803Jul 15, 2025
- Form 40001641172-25-019801Jul 15, 2025
- Form 40001641172-25-019800Jul 15, 2025
- Form 40001641172-25-006070Apr 25, 2025
- Form 40001493152-25-000306Jan 3, 2025
- Form 40001493152-25-000302Jan 3, 2025
Fundamentals
XBRL · Calidi Biotherapeutics, Inc.Annual figures sourced directly from Calidi Biotherapeutics, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Calidi Biotherapeutics, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 29, 2026
- 10-QQuarterly reportMay 14, 2026
- 8-KMaterial eventMay 14, 2026
- 8-KMaterial eventMay 8, 2026
- DEF 14AProxy statementApr 29, 2026
- 8-KMaterial eventApr 2, 2026
- 10-KAnnual reportMar 27, 2026
- 8-KMaterial eventMar 27, 2026
- 8-KMaterial eventMar 11, 2026
- 8-KMaterial eventFeb 10, 2026
- 8-KMaterial eventJan 29, 2026
- 10-QQuarterly reportNov 13, 2025
- 8-KMaterial eventNov 13, 2025
- 8-KMaterial eventNov 10, 2025
- 8-KMaterial eventOct 31, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2025 | Q4 2025 | $0.00 | — | +0% |
| Millennium Management | Q1 2025 | Q2 2025 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | Q1 2025 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.